Abstract: The presently disclosed subject matter provides compositions and methods comprising isolated antibodies that can recognize human prostate-specific membrane antigen (PSMA). The presently disclosed antibodies can be used to for imaging and therapy of PSMA-expressing cancers, such as prostate cancer, in a subject.
Type:
Grant
Filed:
January 5, 2018
Date of Patent:
October 3, 2023
Assignees:
The Johns Hopkins University, Institute of Biotechnology CAS, V.V.I.
Inventors:
Cyril Barinka, Martin G. Pomper, Zora Novakova, Catherine A. Foss
Abstract: Compounds of general formula I are disclosed. The meaning of individual substituents is described in the claims. The compounds are useful in treatment of cancers, due to their multi-modal mechanism of action.
Type:
Application
Filed:
June 11, 2020
Publication date:
August 11, 2022
Applicants:
INSTITUTE OF BIOTECHNOLOGY CAS, V.V.I., SMART BRAIN S.R.O.
Inventors:
Jaroslav TRUKSA, Lukas WERNER, Jan STURSA, Kristyna BLAZKOVA, Cristian Adrian SANDOVAL ACUNA